8 | ITRM 40% v157M c.337 f183M H0.4678 | znewcar1 | 07/11/2022 4:17:13 PM |
7 | ITRM 40% v42,9M c.7449 f182,7M note increased | znewcar1 | 10/26/2021 4:46:31 PM |
6 | ITRM 47% v228M c2.27 f81,1M preMH2.85 | znewcar1 | 02/09/2021 5:11:02 PM |
5 | ITRM 33% v90,4M c1.74 f49,0M H1.99 S1.6 | znewcar1 | 01/20/2021 10:54:21 PM |
4 | ITRM 42% v27,6M c.820 f43,0M | znewcar1 | 11/24/2020 4:39:30 PM |
3 | ITRM 35% v24,4M c1.15 f21,2M preMH1.5 S1.02 | znewcar1 | 10/20/2020 4:19:52 PM |
2 | ITRM 63% v212M c1.05 f21,2M H2.44 | znewcar1 | 09/30/2020 4:07:02 PM |
1 | ITRM 26% v1,9M c4.38 f14,8M H6.02 | znewcar1 | 05/19/2020 4:33:27 PM |
Recent Articles
- Bioinformatics Market Growth Forecast: Major Trends and Drivers
- Understanding Major Holdings Notification for Investors
- Macy’s, Inc. Reports Impressive Third Quarter Financial Performance
- Roots Canada Achieves Strong Q3 Financial Performance
- Investigation of Patterson Companies: Fair Value Concerns
- Palantir Launches Warp Speed Program to Boost Manufacturing
- Innovations in Psychiatry: Findings from Seaport Therapeutics
- New Resource Website by Chemical Insights for WUI Fire Safety
- Gameday Men's Health Launches Expanded Services in Canada
- Understanding Low Testosterone: Impact on Men's Moods
- ReposiTrak Expands Network with 50 New Diverse Suppliers
- OXIO Partners with AT&T to Transform Telecom Services
- Essential Security Tips for a Happy and Safe Holiday Season
- Ververica Enhances Global Impact Through Innovative Partnerships
- Empowering Parents: Navigating Youth Mental Health Together
- Seaport Therapeutics Showcases Phase 1 Progress of SPT-300
- Exciting Developments Coming with the 2025 Mitsubishi Outlander
- Wynn Resorts Enhances Investor Relations with New Leaders
- Revolutionizing Genetic Treatments: nChroma Bio Emerges Stronger
- Exploring the Future of Advanced Air Mobility with Eve and Signature
- Veradermics Secures $75 Million for Hair Loss Treatment Trial
- Surge in Demand for Non-Associated Cellulose Rheology Modifiers
- Natural Beta Carotene Market Forecast: 4.4% Growth Ahead
- Multiparameter Patient Monitoring Market Growth and Trends
- Mobix Labs Set for Fourth Quarter Earnings Call in December
- Collaboration to Boost Cancer Immunotherapy with PLEX Tech
- Evergold Corp. Reports Promising Antimony Drill Results
- Collaborative Carbon Capture Efforts from CarbonQuest and Carbfix
- Falco Resources Elects New Directors and Finalizes Debt Deals
- Adams Clinical Expands Psychiatry Research with New Partnership
- CareDx Teams Up with TC BioPharm for Innovative Clinical Trials
- Candel Therapeutics Reports Promising Phase 3 Results for CAN-2409
- Octapharma Enhances Supply Chain Efficiency with Kinaxis
- Boralex Secures $538 Million for Major Energy Storage Project
- IISc and Ittiam Systems Forge Partnership in AI Innovation
- Rafael Holdings Shows Resilience in Q1 Fiscal 2025 Results
- Enhancing Electronic Warfare: Pacific Defense's New AI Contract
- Simply Good Foods Prepares to Share Q1 Financial Insights
- Satellos Takes Significant Step in DMD Treatment with SAT-3247
- Monte Rosa's New Licensing Deal with Novartis: A Game Changer
- Bloomreach Commits to Community Service with Pledge 1% Initiative
- New Advances in Treating HR-positive Breast Cancer Revealed
- ExxonMobil's Vision for 2030: Driving Sustainable Growth
- Tilray Expands Festive THC Beverage Offerings with XMG and Mollo
- Bio-Path Holdings Advances BP1001-A for Diabetes and Obesity
- Mongolian Mining Corporation Joins OTCQX for Greater Reach
- Fiduciary Trust Company Welcomes Puneet Nevatia as COO
- Ocugen CEO Set to Discuss Innovations at Rare Disease Summit
- Strategic Partnership: ZEDRA and Gryphon Enhance Fund Solutions
- Cognyte Shows Strong Growth in Third Quarter FY 2025 Results